18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey

18-24-month HIV-free survival as measurement of the effectiveness of prevention of mother-to-child transmission in the context of lifelong antiretroviral therapy: Results of a community-based survey

Show other versions (1)

Introduction Population-based HIV-free survival at 18–24 months of age among HIV-exposed infants in high prevalence settings in the era of treatment for all is largely unknown. We conducted a community-based survey to determine outcomes of HIV-exposed infants at 18–24 months in Lesotho. Methods Betw...

Full description

Bibliographic Details
Main Authors: Appolinaire Tiam, Michelle M. Gill, Rhoderick Machekano, Vincent Tukei, Majoalane Mokone, Shannon Viana, Mosilinyane Letsie, Mots’oane Tsietso, Irene Seipati, Cecilia Khachane, Marethabile Nei, Florence Mohai, Thorkild Tylleskär, Laura Guay, Kwasi Torpey
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529246/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529246/?tool=EBI

Similar Items